OtherCELLULAR AND MOLECULAR PHARMACOLOGY
SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor
Murielle Rinaldi-Carmona, Francis Barth, José Millan, Jean-Marie Derocq, Pierre Casellas, Christian Congy, Didier Oustric, Martine Sarran, Monsif Bouaboula, Bernard Calandra, Marielle Portier, David Shire, Jean-Claude Brelière and Gérard Le Fur
Journal of Pharmacology and Experimental Therapeutics February 1998, 284 (2) 644-650;
Murielle Rinaldi-Carmona
Francis Barth
José Millan
Jean-Marie Derocq
Pierre Casellas
Christian Congy
Didier Oustric
Martine Sarran
Monsif Bouaboula
Bernard Calandra
Marielle Portier
David Shire
Jean-Claude Brelière
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 284, Issue 2
1 Feb 1998
OtherCELLULAR AND MOLECULAR PHARMACOLOGY
SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor
Murielle Rinaldi-Carmona, Francis Barth, José Millan, Jean-Marie Derocq, Pierre Casellas, Christian Congy, Didier Oustric, Martine Sarran, Monsif Bouaboula, Bernard Calandra, Marielle Portier, David Shire, Jean-Claude Brelière and Gérard Le Fur
Journal of Pharmacology and Experimental Therapeutics February 1, 1998, 284 (2) 644-650;
OtherCELLULAR AND MOLECULAR PHARMACOLOGY
SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor
Murielle Rinaldi-Carmona, Francis Barth, José Millan, Jean-Marie Derocq, Pierre Casellas, Christian Congy, Didier Oustric, Martine Sarran, Monsif Bouaboula, Bernard Calandra, Marielle Portier, David Shire, Jean-Claude Brelière and Gérard Le Fur
Journal of Pharmacology and Experimental Therapeutics February 1, 1998, 284 (2) 644-650;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement